Dr. Barry Dworkin

Health Canada adds Capillary Leak Syndrome, as an extremely rare side effect of AZ and Covishield vaccine. Six people in Europe and UK reported had syndrome after vaccine out of 78 million doses given. One case in Canada reported to date. #FullDisclosure

Medical Mythbusting Commentary for June 30, 2021

Source:
Health Canada adds warning of very rare, serious condition as potential vaccine side-effect

Related posts:

  1. Short-lived common side effects including fever, chills, pain, and headache after mixing AZ with Pfizer vaccine reported in @TheLancet. Immunogenicity results to be reported in June and if mixing is a viable option (likely but assumption needs evidence).
  2. 2014-15 flu shot was ineffective because the virus mutated after vaccine went into production
  3. Risk calculus and interpretation changing in Ontario. Public Health recommends suspending first dose of AZ vaccine pending further data analysis. Outcome even if in favour of resumption will not change the erosion of public confidence.
  4. Ontario to expand eligibility of COVID-19 boosters for adults 50 and older finally recognizing that this is a three-dose vaccine. #VaccinesWork